1,518 results on '"Kaye, David M."'
Search Results
2. HeartMate 3 for Heart Failure with Preserved Ejection Fraction: In Vitro Hemodynamic Evaluation and Anatomical Fitting
3. Heart failure with preserved ejection fraction: The role of inflammation
4. 2-Year Outcomes of an Atrial Shunt Device in HFpEF/HFmrEF: Results From REDUCE LAP-HF II
5. Electrocardiographic patterns and clinical outcomes of acute coronary syndrome cardiogenic shock in patients undergoing percutaneous coronary intervention — A propensity score analysis
6. ECMO PAL: using deep neural networks for survival prediction in venoarterial extracorporeal membrane oxygenation
7. Acute Kidney Injury after Heart Transplantation: Risk Stratification is Good; Risk Modification is Better—But can we do it?
8. Long term safety and outcomes after atrial shunting for heart failure with preserved or mildly reduced ejection fraction: 5-year and 3-year follow-up in the REDUCE LAP-HF I and II trials
9. The burden of atrial fibrillation on emergency medical services: A population-based cohort study
10. Making Waves in HFpEF: Unmasking Severe Left Atrial Myopathy During Exercise
11. Comparison of Characteristics and Outcomes in Patients With Acute Decompensated Heart Failure Admitted Under General Medicine and Cardiology Units
12. The Efficacy of Risk Factor Modification Compared to NAD+ Repletion in Diastolic Heart Failure
13. The Impact of Diabetes on Haemodynamic and Cardiometabolic Responses in Heart Failure With Preserved Ejection Fraction
14. Cardiac Substrate Utilization and Relationship to Invasive Exercise Hemodynamic Parameters in HFpEF
15. Hypothermic oxygenated perfusion (HOPE) safely and effectively extends acceptable donor heart preservation times: Results of the Australian and New Zealand trial
16. No-Reflow Prediction in Acute Coronary Syndrome During Percutaneous Coronary Intervention: The NORPACS Risk Score
17. Device therapy with interatrial shunt devices for heart failure with preserved ejection fraction
18. Sex Differences in Pharmacotherapy and Long-Term Outcomes in Patients With Ischaemic Heart Disease and Comorbid Left Ventricular Dysfunction
19. Effect of Concomitant Cardiac Arrest on Outcomes in Patients With Acute Coronary Syndrome-Related Cardiogenic Shock
20. Exercise-Induced Left Atrial Hypertension in Heart Failure With Preserved Ejection Fraction
21. Prebiotic intervention with HAMSAB in untreated essential hypertensive patients assessed in a phase II randomized trial
22. Early versus deferred coronary angiography following cardiac arrest. A systematic review and meta-analysis
23. Atrial Fibrillation Ablation for Heart Failure With Preserved Ejection Fraction: A Randomized Controlled Trial
24. The effect of drainage cannula tip position on risk of thrombosis during venoarterial extracorporeal membrane oxygenation
25. Opportunities and Challenges of Computed Tomography Coronary Angiography in the Investigation of Chest Pain in the Emergency Department—A Narrative Review
26. Clinical Features and Outcomes Among Patients With Refractory Out-of-Hospital Cardiac Arrest and an Initial Shockable Rhythm
27. Moving towards understanding the "hole" story in HFpEF
28. Immune Checkpoint Inhibitor Myocarditis and Cellular Rejection in Orthotopic Heart Transplant Recipients
29. Impact of Late Referral on Cardiac Transplant Outcomes
30. A gold nanowire-integrated soft wearable system for dynamic continuous non-invasive cardiac monitoring
31. Venous Tone and Stressed Blood Volume in Heart Failure: JACC Review Topic of the Week
32. Methamphetamine-Associated Cardiomyopathy: Addressing the Clinical Challenges
33. Cardiovascular magnetic resonance imaging characteristics in patients with methamphetamine-associated cardiomyopathy
34. Vasoplegia Following Orthotopic Heart Transplantation: Prevalence, Predictors and Clinical Outcomes
35. Atrial shunt device for heart failure with preserved and mildly reduced ejection fraction (REDUCE LAP-HF II): a randomised, multicentre, blinded, sham-controlled trial
36. Characterization of Cardiac Sympathetic Nervous System and Inflammatory Activation in HFpEF Patients
37. Hyperlactataemia is a marker of reduced exercise capacity in heart failure with preserved ejection fraction.
38. Hospital characteristics are associated with clinical outcomes in patients with cardiogenic shock
39. The Gut Microbiota and Their Metabolites in Human Arterial Stiffness
40. Design, Development, In Vitro and Preliminary In Vivo Evaluation of a Novel Photo-Angioplasty Device: Lumi-Solve
41. Abstract 155: Intra-arrest Epinephrine Administration is Associated with Increased Myocardial Injury and Inflammation in a Novel Murine Model of Cardiac Arrest
42. High-intensity interval training in patients with left ventricular assist devices: A pilot randomized controlled trial
43. Characterization of infected, explanted ventricular assist device drivelines: The role of biofilms and microgaps in the driveline tunnel
44. Influence of angiotensin II on the gut microbiome: modest effects in comparison to experimental factors.
45. Device Based Approaches to the Prevention of Contrast-Induced Acute Kidney Injury
46. Long-Term Survival Following Transcatheter Mitral Valve Repair: Pooled Analysis of Prospective Trials with the Carillon Device
47. Levosimendan and continuous outpatient support with inotropes (COSI) in patients with advanced heart failure: a single-centre descriptive study.
48. Indole-3-Propionic Acid Protects Against Heart Failure With Preserved Ejection Fraction
49. Influence of Impaired Conduction on Exercise Hemodynamics in Patients With Preserved Ejection Fraction
50. Understanding the influence of left ventricular assist device inflow cannula alignment and the risk of intraventricular thrombosis
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.